GREAT VALLEY ADVISOR GROUP, INC.
Position in BBIO — BridgeBio Pharma, Inc.
CIK 1769897
WILMINGTON, DE
Position in BBIO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$201,096
-$80,124 QoQ
Shares Held
2,700
-55.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#346
of 469 holders
Holding Since
Jun 2021
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GREAT VALLEY ADVISOR GROUP, INC. holds $5,771,539 across 13 Biotechnology names. BBIO ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
2,947 | $2,734,138 | |
| 2 | CELC |
Celcuity Inc.
|
5,591 | $584,930 | |
| 3 | INCY |
Incyte Corp
|
5,040 | $571,334 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
874 | $434,142 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
25,840 | $376,488 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,080 | $260,247 | |
| 7 | REGN |
Regeneron Pharmaceuticals, Inc.
|
379 | $236,321 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
This page
|
2,700 | $201,096 |
All Filings in BBIO
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $201,096 | 2,700 | Shares | Sole | 2026-08-10 | |
| 2021-09-30 | $281,220 | 6,000 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $365,760 | 6,000 | Shares | Sole | 2021-07-27 | |
| No filing history on record for this holder in this stock. | ||||||